BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 15660649)

  • 1. Cutaneous carcinosarcoma: adnexal vs. epidermal types define high- and low-risk tumors. Results of a meta-analysis.
    Tran TA; Muller S; Chaudahri PJ; Carlson JA
    J Cutan Pathol; 2005 Jan; 32(1):2-11. PubMed ID: 15660649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-grade trichoblastic carcinosarcoma.
    Kazakov DV; Vittay G; Michal M; Calonje E
    Am J Dermatopathol; 2008 Feb; 30(1):62-4. PubMed ID: 18212548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathological and immunohistochemical characteristics of esophageal carcinosarcoma.
    Sano A; Sakurai S; Kato H; Sakai M; Tanaka N; Inose T; Saito K; Sohda M; Nakajima M; Sakamoto K; Sano T; Hosoya Y; Enomoto T; Kanda T; Ajioka Y; Oyama T; Kuwano H
    Anticancer Res; 2009 Aug; 29(8):3375-80. PubMed ID: 19661359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Case report and literature review: primary cutaneous carcinosarcoma.
    Ram R; Saadat P; Peng D; Vadmal M
    Ann Clin Lab Sci; 2005; 35(2):189-94. PubMed ID: 15943184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Squamous cell carcinoma with clear cells: how often is there evidence of tricholemmal differentiation?
    Dalton SR; LeBoit PE
    Am J Dermatopathol; 2008 Aug; 30(4):333-9. PubMed ID: 18645304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristic Ber-EP4 and EMA expression in sebaceoma is immunohistochemically distinct from basal cell carcinoma.
    Fan YS; Carr RA; Sanders DS; Smith AP; Lazar AJ; Calonje E
    Histopathology; 2007 Jul; 51(1):80-6. PubMed ID: 17593083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Basal cell carcinoma with a sarcomatous component (carcinosarcoma): a series of 5 cases and a review of the literature.
    Rose RF; Merchant W; Stables GI; Lyon CL; Platt A
    J Am Acad Dermatol; 2008 Oct; 59(4):627-32. PubMed ID: 18793937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SOX9 expression is a general marker of basal cell carcinoma and adnexal-related neoplasms.
    Vidal VP; Ortonne N; Schedl A
    J Cutan Pathol; 2008 Apr; 35(4):373-9. PubMed ID: 18333897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High expressions of bcl-2 and survivin, and decreased apoptosis in uterine cervical carcinosarcoma compared to cervical squamous cell carcinoma.
    Gan XL; Li JK; Yu TH; Zhang Y; Hu LN
    Arch Gynecol Obstet; 2011 Jul; 284(1):175-81. PubMed ID: 20668868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of S100A6 protein in a broad spectrum of cutaneous tumors using tissue microarrays.
    Fullen DR; Garrisi AJ; Sanders D; Thomas D
    J Cutan Pathol; 2008 Nov; 35 Suppl 2():28-34. PubMed ID: 18201235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p75 Neurotrophin receptor differentiates between morphoeic basal cell carcinoma and desmoplastic trichoepithelioma: insights into the histogenesis of adnexal tumours based on embryology and hair follicle biology.
    Krahl D; Sellheyer K
    Br J Dermatol; 2010 Jul; 163(1):138-45. PubMed ID: 20184585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Podoplanin is a highly sensitive and specific marker to distinguish primary skin adnexal carcinomas from adenocarcinomas metastatic to skin.
    Liang H; Wu H; Giorgadze TA; Sariya D; Bellucci KS; Veerappan R; Liegl B; Acs G; Elenitsas R; Shukla S; Youngberg GA; Coogan PS; Pasha T; Zhang PJ; Xu X
    Am J Surg Pathol; 2007 Feb; 31(2):304-10. PubMed ID: 17255777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Esophageal carcinosarcoma with basaloid squamous carcinoma and rhabdomyosarcoma components with TP53 mutation.
    Amatya VJ; Takeshima Y; Kaneko M; Inai K
    Pathol Int; 2004 Oct; 54(10):803-9. PubMed ID: 15482572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cutaneous basal cell carcinosarcoma: case report and literature review.
    Zbacnik AP; Rawal A; Lee B; Werling R; Knapp D; Mesa H
    J Cutan Pathol; 2015 Nov; 42(11):903-10. PubMed ID: 26268472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidermal growth factor receptor: a novel biomarker for aggressive head and neck cutaneous squamous cell carcinoma.
    Ch'ng S; Low I; Ng D; Brasch H; Sullivan M; Davis P; Tan ST
    Hum Pathol; 2008 Mar; 39(3):344-9. PubMed ID: 18045646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary cutaneous metaplastic carcinoma: report of a case involving angiosarcoma.
    Kantrow SM; Boyd AS
    Am J Dermatopathol; 2007 Jun; 29(3):270-3. PubMed ID: 17519625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative analysis of immunohistochemical markers with invasiveness and histologic differentiation in squamous cell carcinoma and basal cell carcinoma of the skin.
    Son KD; Kim TJ; Lee YS; Park GS; Han KT; Lim JS; Kang CS
    J Surg Oncol; 2008 Jun; 97(7):615-20. PubMed ID: 18404670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary cutaneous neuroendocrine cell carcinoma (Merkel cell carcinoma) with prominent microcystic features, mimicking eccrine carcinoma.
    Li N; Wolgamot G; Argenyi Z
    J Cutan Pathol; 2007 May; 34(5):410-4. PubMed ID: 17448197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Skin metastasis from the spindle cell component in rectal carcinosarcoma.
    Takeyoshi I; Yoshida M; Ohwada S; Yamada T; Yanagisawa A; Morishita Y
    Hepatogastroenterology; 2000; 47(36):1611-4. PubMed ID: 11149014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monoclonal antibody Ber-EP4 reliably discriminates between microcystic adnexal carcinoma and basal cell carcinoma.
    Krahl D; Sellheyer K
    J Cutan Pathol; 2007 Oct; 34(10):782-7. PubMed ID: 17880584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.